A Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients

NCT03884959 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decided to stop enrollment

Conditions

Urea Cycle Disorder

Interventions

BIOLOGICAL: HepaStem Infusion

Sponsor

HLB Cell Co., Ltd.